◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › X › XRAY

Dentsply Sirona Inc (XRAY) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · DATA UPDATED 2026-09-06

Dentsply Sirona Inc (XRAY) operates in the MEDICAL INSTRUMENTS & SUPPLIES industry and is headquartered in Charlotte, United States with about 14,000 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, XRAY reported $3.7B in revenue and ($598M) in net income.

DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide.

Interactive charts & full statements → Open the XRAY valuation workbench →

XRAY Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$3.6B	$3.7B	$3.8B	$4.0B	$3.9B	$4.2B	$3.3B	$4.0B	$4.0B	$4.0B	$3.7B	$2.7B	$2.9B	$3.0B	$2.9B	$2.5B	$2.2B	$2.2B	$2.2B	$2.0B	$1.8B
Gross Profit	$1.8B	$1.8B	$2.0B	$2.1B	$2.1B	$2.3B	$1.7B	$2.2B	$2.1B	$2.2B	$2.0B	$1.5B	$1.6B	$1.6B	$1.6B	$1.3B	$1.1B	$1.1B	$1.2B	$1.0B	$929M
Gross Margin %	49.5%	50.0%	51.6%	52.6%	54.2%	55.5%	49.6%	53.8%	51.9%	54.8%	53.4%	56.7%	54.7%	53.5%	53.1%	50.2%	50.9%	51.4%	52.5%	51.8%	51.3%
Operating Income (EBIT)	$426M	$252M	($879M)	($85M)	($937M)	$608M	($3M)	$353M	($958M)	($1.6B)	$455M	$375M	$446M	$419M	$382M	$301M	$380M	$381M	$380M	$355M	$315M
Operating Margin %	11.7%	6.9%	-23.2%	-2.1%	-23.9%	14.4%	-0.1%	8.8%	-24.0%	-39.7%	12.1%	14.0%	15.2%	14.2%	13.0%	11.8%	17.1%	17.6%	17.3%	17.7%	17.4%
Net Income	($546M)	($598M)	($910M)	($132M)	($950M)	$411M	($73M)	$256M	($1.0B)	($1.6B)	$430M	$251M	$323M	$313M	$314M	$245M	$266M	$274M	$284M	$260M	$224M
Net Margin %	-15.0%	-16.2%	-24.0%	-3.3%	-24.2%	9.7%	-2.2%	6.4%	-25.4%	-38.8%	11.5%	9.4%	11.1%	10.6%	10.7%	9.6%	12.0%	12.7%	12.9%	12.9%	12.4%
EBITDA	$172M	($46M)	($518M)	$249M	($662M)	$952M	$330M	$688M	($585M)	($1.3B)	$770M	$579M	$575M	$545M	$513M	$379M	$440M	$437M	$444M	$432M	$373M
Earnings Per Share (EPS)	$-2.74	$-3.00	$-4.48	$-0.62	$-4.41	$1.87	$-0.33	$1.14	$-4.51	$-6.76	$1.94	$1.76	$2.24	$2.16	$2.18	$1.70	$1.82	$1.83	$1.87	$1.68	$1.41
Shares Outstanding (M)	200M	199M	203M	212M	216M	220M	219M	224M	224M	229M	222M	142M	144M	145M	144M	144M	146M	150M	152M	155M	158M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRAY Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$898M	$880M	$961M	$904M	$936M	$879M	$905M	$951M
Gross Profit	$493M	$427M	$443M	$441M	$490M	$466M	$446M	$495M
Gross Margin %	54.9%	48.5%	46.1%	48.8%	52.3%	53.0%	49.3%	52.0%
Operating Income (EBIT)	$82M	$30M	$268M	$46M	($128M)	$63M	($509M)	($462M)
Operating Margin %	9.1%	3.4%	27.9%	5.1%	-13.7%	7.2%	-56.2%	-48.6%
Net Income	$37M	($10M)	($146M)	($427M)	($45M)	$20M	($430M)	($494M)
Net Margin %	4.1%	-1.1%	-15.2%	-47.2%	-4.8%	2.3%	-47.5%	-51.9%
EBITDA	$258M	$61M	($32M)	($115M)	($41M)	$150M	($419M)	($371M)
Earnings Per Share (EPS)	$0.18	$-0.05	$-0.73	$-2.14	$-0.23	$0.10	$-2.12	$-2.46
Shares Outstanding (M)	200M	200M	200M	200M	199M	200M	203M	201M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRAY Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$319M	$235M	$461M	$377M	$517M	$657M	$635M	$633M	$500M	$602M	$563M	$497M	$560M	$418M	$370M	$393M	$362M	$362M	$336M	$388M	$272M
Capital Expenditures (CapEx)	$176M	$131M	$180M	$149M	$149M	$142M	$87M	$123M	$188M	$151M	$126M	$72M	$106M	$101M	$95M	$74M	$46M	$56M	$79M	$66M	$53M
Free Cash Flow (FCF)	$143M	$104M	$281M	$228M	$368M	$515M	$548M	$510M	$312M	$451M	$437M	$425M	$455M	$316M	$274M	$319M	$316M	$306M	$257M	$322M	$219M
FCF Margin %	3.9%	2.8%	7.4%	5.8%	9.4%	12.2%	16.4%	12.7%	7.8%	11.3%	11.7%	15.9%	15.6%	10.7%	9.4%	12.6%	14.2%	14.2%	11.7%	16.0%	12.1%
Dividends Paid	$128M	$128M	$126M	$116M	$104M	$92M	$88M	$81M	$79M	$78M	$65M	$40M	$37M	$35M	$31M	$29M	$29M	$30M	$27M	$25M	$22M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRAY Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$99M	$40M	$101M	$79M	$48M	$7M	$87M	$141M
Capital Expenditures (CapEx)	$44M	$52M	$41M	$39M	$32M	$19M	$51M	$43M
Free Cash Flow (FCF)	$55M	($12M)	$60M	$40M	$16M	($12M)	$36M	$98M
FCF Margin %	6.1%	-1.4%	6.2%	4.4%	1.7%	-1.4%	4.0%	10.3%
Dividends Paid	$32M	$32M	$32M	$32M	$32M	$32M	$31M	$33M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

XRAY Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$5.2B	$5.4B	$5.8B	$7.4B	$7.6B	$9.2B	$9.3B	$8.6B	$8.7B	$10.4B	$11.7B	$4.4B	$4.7B	$5.1B	$5.0B	$4.8B	$3.3B	$3.1B	$2.8B	$2.7B	$2.2B
Cash & Cash Equivalents	$239M	$326M	$272M	$334M	$365M	$339M	$438M	$405M	$310M	$321M	$384M	$285M	$152M	$75M	$80M	$77M	$540M	$450M	$204M	$169M	$65M
Total Liabilities	$3.9B	$4.1B	$3.8B	$4.1B	$3.8B	$4.2B	$4.4B	$3.5B	$3.6B	$3.7B	$3.5B	$2.1B	$2.3B	$2.5B	$2.7B	$2.9B	$1.3B	$1.2B	$1.2B	$1.2B	$907M
Total Debt (Short + Long-Term)	$2.2B	$2.4B	$2.2B	$2.2B	$2.0B	$2.1B	$2.3B	$1.5B	$1.7B	$1.6B	$1.5B	$1.2B	$1.3B	$1.5B	$1.5B	$1.8B	$612M	$469M	$449M	$483M	$370M
Total Shareholders' Equity	$1.4B	$1.3B	$1.9B	$3.3B	$3.8B	$5.0B	$4.9B	$5.1B	$5.1B	$6.6B	$8.1B	$2.3B	$2.3B	$2.6B	$2.2B	$1.9B	$1.9B	$1.9B	$1.6B	$1.5B	$1.3B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XRAY viewer.

Other Companies in MEDICAL INSTRUMENTS & SUPPLIES

PLSE · Pulse Biosciences Inc — $4 billion
ICUI · ICU Medical Inc — $4 billion
NVST · Envista Holdings Corp — $4 billion
ATRC · AtriCure Inc — $3 billion
LMAT · LeMaitre Vascular Inc — $2 billion
BLFS · BioLife Solutions Inc — $2 billion
AZTA · Azenta Inc — $1 billion
KMTS · Kestra Medical Technologies, Ltd. Common Stock — $1 billion

← XQUI All “X” companies XREA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.